Astrazeneca PLC News Headlines

AZN 
$71.69
*  
0.42
0.58%
Get AZN Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading AZN now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    AZN After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Sector Update: Health Care
8/19/2014 7:26:09 AM - MT Newswires


Kindred 30.33% Upside Paced Healthcare August Dividend Dogs
8/18/2014 9:18:00 PM - Seeking Alpha


A Dividend Growth Portfolio For New Investors And Retirees Yielding 4.3%, Part 2
8/18/2014 4:29:00 PM - Seeking Alpha


AstraZeneca's Asthma Drug in Focus, Phase III Study Initiated - Analyst Blog
8/18/2014 4:20:00 PM - Zacks.com


Mallinckrodt Acquires Questcor, to Join S&P 500 As Well - Analyst Blog
8/18/2014 3:30:00 PM - Zacks.com


Roche's Avastin Approved by FDA for Advanced Cervical Cancer - Analyst Blog
8/18/2014 1:30:00 PM - Zacks.com


European ADRs Hit Two-Week High on Telecommunication Gains
8/18/2014 9:46:51 AM - MT Newswires


2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha


AstraZeneca's Gout Drug in Focus with Phase III Data Readout - Analyst Blog
8/15/2014 3:45:00 PM - Zacks.com


Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog
8/14/2014 4:10:00 PM - Zacks.com


Merck's Insomnia Drug Belsomra Approved by the FDA - Analyst Blog
8/14/2014 4:00:00 PM - Zacks.com


Dynavax Is More Than Just HEPLISAV
8/13/2014 6:16:00 PM - Seeking Alpha


Why Tax Inversions Won't Go Away
8/13/2014 2:20:00 PM - Seeking Alpha


Cel-Sci Is A Leader In The I-O Class Of Cancer Therapies
8/12/2014 10:43:00 AM - Seeking Alpha


For Lexicon Pharmaceuticals, No News Remains Bad News
8/11/2014 1:00:00 PM - Seeking Alpha


Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat - Analyst Blog
8/8/2014 3:22:00 PM - Zacks.com


Novo Nordisk's Earnings Rise on Solid Victoza, Levemir Sales - Analyst Blog
8/8/2014 3:10:00 PM - Zacks.com


OncoGenex Q2 Loss Narrower than Expected, Revenues Down Y/Y - Analyst Blog
8/8/2014 3:00:00 PM - Zacks.com


Charles River Beats on Q2 Earnings & Revenues, Outlook Upped - Analyst Blog
8/7/2014 1:10:00 PM - Zacks.com


Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik
8/7/2014 12:36:00 PM - Seeking Alpha


An Investing Legend Predicts A Major M&A Boom -- Here's How To Profit
8/7/2014 8:30:00 AM - Investopedia


Isis Pharmaceuticals Posts Narrower-Than-Expected Q2 Loss - Analyst Blog
8/7/2014 8:10:00 AM - Zacks.com


European ADRs Slip 0.7% as Ukraine-Russia Tension, Italy Recession, Weak German Factory Orders Weigh on Sentiment
8/6/2014 9:26:16 AM - MT Newswires


Update: Pfizer Can Not Afford GlaxoSmithKline
8/6/2014 9:03:00 AM - Seeking Alpha


Pre-Market Most Active for Aug 6, 2014 : S, WAG, TWX, QQQ, ABBV, AZN, TMUS, CTSH, GRPN, TVIX, XIV, MNKD
8/6/2014 7:38:59 AM - NASDAQ.com News